{"id":1380,"date":"2009-12-09T13:49:58","date_gmt":"2009-12-09T18:49:58","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/bleeding-with-pci-were-making-the-problem-worse\/"},"modified":"2011-07-19T17:44:18","modified_gmt":"2011-07-19T21:44:18","slug":"bleeding-with-pci-were-making-the-problem-worse","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2009\/12\/09\/bleeding-with-pci-were-making-the-problem-worse\/","title":{"rendered":"Bleeding With PCI: We\u2019re Making The Problem Worse"},"content":{"rendered":"<p>In a recent <a href=\"http:\/\/content.nejm.org\/cgi\/reprint\/360\/21\/2237.pdf\">editorial <\/a>regarding the management of ACS patients, we emphasized the importance of early risk stratification to identify patients who would most benefit (or not benefit) from intensive antithrombotic therapy or an invasive cardiac procedure.\u00a0 <\/p>\n<p>However, a recently published <a href=\"http:\/\/jama.ama-assn.org\/cgi\/reprint\/302\/22\/2458\">study <\/a>reported that 22% of dialysis patients \u00a0undergoing PCI received an antithrombotic agent (enoxaparin or eptifibatide) that was contraindicated in individuals with renal disease. \u00a0Not surprisingly, the use of these agents was associated with an increased risk of major bleeding and death.\u00a0 <\/p>\n<p>As inverventionalists, do we know how to assess (and minimize) bleeding risks in our PCI patients?\u00a0 <\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a recent editorial regarding the management of ACS patients, we emphasized the importance of early risk stratification to identify patients who would most benefit (or not benefit) from intensive antithrombotic therapy or an invasive cardiac procedure.\u00a0 However, a recently published study reported that 22% of dialysis patients \u00a0undergoing PCI received an antithrombotic agent (enoxaparin [&hellip;]<\/p>\n","protected":false},"author":214,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,9],"tags":[],"class_list":["post-1380","post","type-post","status-publish","format-standard","hentry","category-general","category-interventional-cardiology"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/214"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1380"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1380\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}